Legal Disclaimer

All products on this site are for research and development, laboratory, or analytical use only; they are not for human consumption, medical, diagnostic, cosmetic, veterinary, or The statements and products have not been evaluated by the U.S. Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease. Vitacelle Labs is not a compounding pharmacy or chemical compounding facility as defined under section 503A of the Federal Food, Drug, and Cosmetic Act, nor an outsourcing facility as defined under section 503B.

TESAMORELIN

$79.99 USD

Sale Sold out

Tesamorelin is a synthetic peptide analogue of growth hormone–releasing hormone (GHRH), composed of a 44-amino acid sequence that has been structurally modified to enhance molecular stability and resistance to enzymatic degradation. This modification allows tesamorelin to retain biological activity for extended periods when compared with native GHRH, making it a compound of interest within controlled laboratory and investigative research environments.

size 20mg

Save up to 15% when you buy more!

Quantity	Discount	Price
1	0%	$79.99
2 - 5	5%	$75.99
6 - 10	10%	$71.99
11 - 15	15%	$67.99

Product details

Mechanistic Selectivity

Specifically binds to and activates the GHRH receptor, promoting endogenous pulsatile GH release while mimicking physiological secretion patterns and avoiding negative feedback inhibition associated with direct GH administration.

Rigorous Quality Control and Stability

High-purity laboratory-grade material ensures reliable and accurate experimental data, specifically designed for tissue repair and cellular function research to support consistent results.

Stable and Easy-to-Use Formulation

Highly stable formulation, easy to handle and reconstitute under standard laboratory conditions.

Mechanism of action

Tesamorelin selectively activates pituitary GHRH receptors (GHRH-R), stimulating pulsatile release of endogenous growth hormone (GH). Elevated GH further promotes hepatic synthesis of insulin-like growth factor 1 (IGF-1), collectively acting on adipose tissue to:

Promote lipolysis: Enhance lipase activity, reducing visceral fat accumulation

Inhibit lipogenesis: Downregulate fatty acid synthase (FAS) expression, decreasing de novo fat synthesis

Improve insulin sensitivity: Modulate adipokines such as adiponectin to ameliorate glucolipid metabolic disorders

Usage Guidelines (Research UseOnly):

Reconstitute using sterile saline or a specified buffer.

Store lyophilized powder sealed and protected from light at -20°C or below. After reconstitution, aliquot and freeze to avoid repeated freeze-thaw cycles to maintain peptide stability.

Suitable for in vitro wound healing assays, cell migration/proliferation analyses, or subcutaneous/intramuscular injection studies in animal models.

Specific dosage, frequency, and administration routes should be optimized based on published literature and preliminary experimental results, while strictly adhering to animal research ethical guidelines.

Packaging Instructions

Packaging Note: This product is supplied in a sealed, sterile glass vial without any pre‑printed labels. This design supports institutional compliance protocols and allows researchers to apply custom labels that align with specific experimental protocols, ethical approvals, and local regulations. A separate document containing complete product details (name, batch number, purity, content, COA reference, etc.) is included for label customization and record‑keeping.

View full details